Saba reports 7.94% stake in BlackRock BSTZ
Saba Capital Management and related reporting persons filed Amendment No. 10 to a Schedule 13D disclosing their beneficial ownership in BlackRock Science & Technology Term Trust.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Saba Capital Management and related reporting persons filed Amendment No. 10 to a Schedule 13D disclosing their beneficial ownership in BlackRock Science & Technology Term Trust. They report holding 5,458,908 common shares, representing 7.94% of the outstanding shares, based on 68,744,150 shares outstanding as of 12/31/25.
The position is held with shared voting and dispositive power across Saba Capital, Saba Capital Management GP, LLC and Boaz R. Weinstein. The filing states that approximately $93,845,617 was paid to acquire these shares using investor subscription proceeds, capital appreciation and ordinary-course margin borrowings. Recent transactions from 1/15/26 through 3/13/26 were executed in the open market.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in BlackRock Science & Technology Term Trust (BSTZ) did Saba Capital disclose?
How much did Saba Capital pay to acquire its BSTZ position?
What period of BSTZ trading activity does this Schedule 13D/A amendment cover?
Who are the reporting persons in the BSTZ Schedule 13D/A Amendment No. 10?
How was the 7.94% ownership in BSTZ calculated in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.